Categories Earnings, Health Care
Earnings Summary: Gilead Sciences reports higher Q2 revenue and profit
Gilead Sciences, Inc. (NASDAQ: GILD), a leading research-based biopharmaceutical company, has reported an increase in revenues and adjusted earnings for the second quarter of 2024.
- Second-quarter revenue increased 5% from last year to $7.0 billion, aided by higher product sales in HIV, Liver Disease, and Oncology
- Earnings, on a per-share basis, were $1.29 in the second quarter, compared to $0.83 in the same period in 2023
- Adjusted earnings per share increased to $2.01 in the June quarter from $1.34 in the prior-year period
- Net income attributable to Gilead advanced to $1.61 billion in Q2 from $1.05 billion in the year-ago quarter
- As of June 30, 2024, the company had $2.8 billion of cash, cash equivalents, and marketable debt securities, vs. $8.4 billion a year earlier
- During the quarter, Gilead generated $1.3 billion in operating cash flow; it paid dividends of $972 million and repurchased $100 million of common stock
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
KB Home’s Q3 results expected to benefit from built-to-order model, stable demand
KB Home (NYSE: KBH) has been resilient to challenges like high mortgage rates and the inflation-induced strain on family budgets, while benefitting from the recovery in the housing market. When
Signet Jewelers (SIG) reports lower Q2 2025 sales and adj. profit
Signet Jewelers Limited (NYSE: SIG) has reported a decline in net sales and adjusted earnings for the second quarter of 2025. Same-store sales declined 3.4% during the three months. Net
Adobe reports higher Q3 revenue and earnings; results beat estimates
Design software maker Adobe Inc. (NASDAQ: ADBE) on Thursday reported an increase in third-quarter 2024 revenue and earnings. The results also topped expectations. Third-quarter revenues came in at $5.41 billion,
